Minimally Invasive Surgical (MIS) Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

MIS Devices Pipeline Market Report Overview

MIS is a term used to describe either a smaller incision (typically half of the length of the traditional incision) or an approach that does not involve cutting tendons or splitting muscles. MIS stands for Minimally invasive surgery.

The MIS Devices pipeline market research report provides comprehensive information about the MIS devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Territories ·        Global

·        United States

·        China

·        Europe

·        Israel

Key Regulatory Paths ·        510(k)

·        CE

·        NMPA

·        de novo

Leading Companies ·        Actuated Medical Inc

·        BariaTek Medical SAS

·        Boston Scientific Corp

·        Delft University of Technology

·        Distalmotion SA

·        Eindhoven University of Technology

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

MIS Devices Pipeline Market Segmentation by Territories

Some of the key territories in the MIS devices market are Global, the United States, China, Europe, and Israel. As of October 2023, the global market besides the above-mentioned countries has the highest number of pipeline products.

MIS Devices Pipeline Market Analysis by Territories, 2023 (%)

MIS Devices Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into the MIS Devices Pipeline Market

Download a Free Report Sample

MIS Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the MIS devices pipeline market are 510(k), CE, NMPA, and de novo. As of October 2023, 510(k) is the most followed pathway for pipeline products in the market.

MIS Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

MIS Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into the MIS Devices Pipeline Market

Download a Free Report Sample

MIS Devices Pipeline Market – Competitive Landscape

Some of the key companies in the MIS devices pipeline market are Actuated Medical Inc, BariaTek Medical SAS, Boston Scientific Corp, Delft University of Technology, Distalmotion SA, and Eindhoven University of Technology.

Actuated Medical Inc: It is a medical device company that develops minimally invasive instruments. The company provides products such as controlled tissue penetration systems, occlusion clearing systems, and MRI-compatible systems. Its controlled tissue penetration systems use low force, electronically controlled motion to enable smooth insertion of sharps for serial blood sampling procedures. Actuated medicals also provide tube-clearing solutions that remove clogs in patients. The company’s occlusion-clearing systems use mechanical motion to restore the patency of tubes in the patient for clearing clogged nasoenteral, gastrostomy, nasogastric, and jejunostomy feeding and decompression tubes. It operates through a manufacturing facility in Bellefonte. Actuated Medical is headquartered in Bellefonte, Pennsylvania, the US.

MIS Devices Pipeline Market Analysis by Companies, 2023

MIS Devices Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the MIS Devices Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

MIS Devices Pipeline Market Territories Outlook

  • Global
  • United States
  • China
  • Europe
  • Israel

MIS Devices Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • de novo

Scope

This report provides:

  • Extensive coverage of the MIS Devices under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of MIS Devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Actuated Medical Inc
BariaTek Medical SAS
Boston Scientific Corp
Delft University of Technology
Distalmotion SA
Eindhoven University of Technology
ES Vascular Ltd.
Ethicon Endo-Surgery Inc
Ezisurg Medical Co Ltd
GT Metabolic Solutions
Imperial College London
Intuitive Surgical Inc
Jiangsu Jiyuan Medical Technology Co Ltd
Johns Hopkins University
Lapovations LLC
LXS Inc
Medacta Group SA
NanoLite Systems Inc
Osaka University
Prana Thoracic Inc
Purdue University
Qingdao Jianxin Medical Technology Co Ltd
Rambam Health Care Campus
Ronovo Surgical (Shanghai) Medical Science and Technology Ltd
Signum Surgical Ltd
Stanford University
UltraSurge Technologies Ltd.
University of South Florida
University of Wisconsin Madison
Varada Innovations Inc.
VenX Medical LLC (Inactive)
Virginia Commonwealth University
West Virginia University

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 10

2.1 Minimally Invasive Surgical (MIS) devices Overview 10

3 Products under Development 11

3.1 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 11

3.2 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Territory 12

3.3 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Regulatory Path 13

3.4 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Estimated Approval Date 14

3.5 Minimally Invasive Surgical (MIS) devices – Ongoing Clinical Trials 15

4 Minimally Invasive Surgical (MIS) devices – Pipeline Products under Development by Companies 16

4.1 Minimally Invasive Surgical (MIS) devices Companies – Pipeline Products by Stage of Development 16

4.2 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 18

5 Minimally Invasive Surgical (MIS) devices Companies and Product Overview 20

5.1 Actuated Medical Inc Company Overview 20

5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 BariaTek Medical SAS Company Overview 21

5.2.1 BariaTek Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 Boston Scientific Corp Company Overview 24

5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 Delft University of Technology Company Overview 25

5.4.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 Distalmotion SA Company Overview 27

5.5.1 Distalmotion SA Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Eindhoven University of Technology Company Overview 29

5.6.1 Eindhoven University of Technology Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 ES Vascular Ltd. Company Overview 30

5.7.1 ES Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Ethicon Endo-Surgery Inc Company Overview 31

5.8.1 Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Ezisurg Medical Co Ltd Company Overview 32

5.9.1 Ezisurg Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.10 GT Metabolic Solutions Company Overview 33

5.10.1 GT Metabolic Solutions Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 Imperial College London Company Overview 37

5.11.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 Intuitive Surgical Inc Company Overview 38

5.12.1 Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 Jiangsu Jiyuan Medical Technology Co Ltd Company Overview 39

5.13.1 Jiangsu Jiyuan Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.14 Johns Hopkins University Company Overview 40

5.14.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 40

5.15 Lapovations LLC Company Overview 41

5.15.1 Lapovations LLC Pipeline Products & Ongoing Clinical Trials Overview 41

5.16 LXS Inc Company Overview 42

5.16.1 LXS Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.17 Medacta Group SA Company Overview 43

5.17.1 Medacta Group SA Pipeline Products & Ongoing Clinical Trials Overview 43

5.18 NanoLite Systems Inc Company Overview 44

5.18.1 NanoLite Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.19 Osaka University Company Overview 45

5.19.1 Osaka University Pipeline Products & Ongoing Clinical Trials Overview 45

5.20 Prana Thoracic Inc Company Overview 46

5.20.1 Prana Thoracic Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.21 Purdue University Company Overview 47

5.21.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 47

5.22 Qingdao Jianxin Medical Technology Co Ltd Company Overview 48

5.22.1 Qingdao Jianxin Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.23 Rambam Health Care Campus Company Overview 49

5.23.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 49

5.24 Ronovo Surgical (Shanghai) Medical Science and Technology Ltd Company Overview 50

5.24.1 Ronovo Surgical (Shanghai) Medical Science and Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.25 Signum Surgical Ltd Company Overview 51

5.25.1 Signum Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.26 Stanford University Company Overview 52

5.26.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 52

5.27 UltraSurge Technologies Ltd. Company Overview 53

5.27.1 UltraSurge Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53

5.28 University of South Florida Company Overview 54

5.28.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 54

5.29 University of Wisconsin Madison Company Overview 55

5.29.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 55

5.30 Varada Innovations Inc. Company Overview 56

5.30.1 Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

5.31 VenX Medical LLC (Inactive) Company Overview 57

5.31.1 VenX Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57

5.32 Virginia Commonwealth University Company Overview 58

5.32.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 58

5.33 West Virginia University Company Overview 59

5.33.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 59

6 Minimally Invasive Surgical (MIS) devices- Recent Developments 61

6.1 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer 61

6.2 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources 61

6.3 Sep 08, 2023: Mentice Strengthens Leadership Team with the Appointment of Chief Operating Officer (COO) 61

6.4 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 62

6.5 Aug 24, 2023: Surgial Science Sweden Announces Interim Report January – June 2023 62

6.6 Aug 14, 2023: Titan Medical Announces Appointment of Daniel O’Brien to its Board of Directors 63

6.7 Aug 10, 2023: PetVivo Reports First Quarter of Fiscal 2024 Financial Results 63

6.8 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 64

6.9 Jul 20, 2023: Intuitive Announces Second Quarter Earnings 65

6.10 Jul 20, 2023: Intuitive Announces Second Quarter Earnings 66

6.11 Jul 14, 2023: Stille Announces Interim Report Q2 2023 68

6.12 Jul 07, 2023: Mentice Announces to Present the Company’s Interim Report at a Webcast Conference Call On July 20 at 10:00 Cest. 68

6.13 Jul 04, 2023: Titan Medical Reports Voting Results From Annual General Meeting of Shareholders 68

6.14 Jun 26, 2023: Petvivo Holdings to Announce Results for the Year 2023 Ended March 31, 2023 69

6.15 Jun 02, 2023: Adventist Health Hanford Adds Robotic Technology to Surgical Options 69

6.16 May 31, 2023: Titan Medical reports operating and financial results for the fourth quarter and year end 2022 and announces availability of materials for the 2023 annual meeting of shareholders 70

6.17 May 29, 2023: Mentice announces resignation of chief financial officer 71

6.18 May 22, 2023: JCMC Enhanced Vascular Capabilities with New Hybrid Operating Room 71

6.19 May 19, 2023: Titan Medical announces delay in first quarter 2023 filings 72

6.20 May 17, 2023: Trina Lally Joins PetVivo Holdings as the Northeast Business Development Manager 72

6.21 May 17, 2023: Surgical Science Sweden Report from the Annual General Meeting 73

6.22 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 73

6.23 May 02, 2023: LeMaitre Q1 2023 financial results 74

6.24 Apr 14, 2023: Surgical Science Sweden Notice of Annual General Meeting 74

6.25 Apr 13, 2023: Annual shareholders’ meeting in Mentice AB 79

6.26 Apr 12, 2023: Medtronic has a layoff in California 86

6.27 Apr 05, 2023: Stille Notice of Annual General Meeting 86

6.28 Mar 29, 2023: Surgical Innovations Group Announces Audited results for the year ended 31 December 2022 88

6.29 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 89

6.30 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 90

6.31 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions 90

6.32 Feb 23, 2023: LeMaitre Q4 2022 Financial Results 90

6.33 Feb 14, 2023: Titan Medical Announces Executive Leadership Updates and Receipt of Nasdaq Notification Regarding Audit Committee Requirements 91

6.34 Feb 02, 2023: Stille Appointed CEO has Purchased Shares 92

6.35 Jan 23, 2023: PetVivo Holdings to Exhibit at the 44th Lake Tahoe Equine Conference in Incline Village, Nevada 92

6.36 Jan 19, 2023: Torbjörn Sköld Appointed New CEO of Stille AB 93

6.37 Jan 17, 2023: Petvivo Holdings to exhibit at the 2023 Ocala Equine Conference In Ocala, Florida 93

6.38 Jan 13, 2023: Intuitive Surgical Reports Mixed Preliminary Q4 Revenues 94

6.39 Jan 10, 2023: European Association of Cardiovascular Imaging (EACVI) collaborates with Surgical Science to pilot the first online Transesophageal ECHO (TOE) testing 94

6.40 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer 95

6.41 Nov 24, 2022: New GI endoscopic simulation-based curricula to be jointly developed by the american society for gastrointestinal endoscopy (asge) and surgical science 95

6.42 Nov 23, 2022: Medtronic Reports Quarterly Earnings 96

6.43 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 96

6.44 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 102

6.45 Nov 10, 2022: Surgical Science Interim report January-September 2022 102

6.46 Oct 27, 2022: Stille Announces Interim Report Q3 2022 103

6.47 Oct 20, 2022: PetVivo Holdings to Present at LD Micro Main Event XV 103

6.48 Oct 19, 2022: Mentice’s CEO Goran Malmberg to present the company’s interim report at a webcast conference call on October 26 104

6.49 Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022 104

7 Appendix 105

7.1 Methodology 105

7.2 About GlobalData 108

7.3 Contact Us 108

7.4 Disclaimer 108

Table

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 11

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Territory 12

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Regulatory Path 13

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Estimated Approval Date 14

Minimally Invasive Surgical (MIS) devices – Ongoing Clinical Trials 15

Minimally Invasive Surgical (MIS) devices Companies – Pipeline Products by Stage of Development 16

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 18

Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Grip-Act-Reposition (GAR) Miniaturized Stable Working System – Product Status 20

Grip-Act-Reposition (GAR) Miniaturized Stable Working System – Product Description 20

BariaTek Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 21

Bariatric Minimally Invasive Device – Product Status 21

Bariatric Minimally Invasive Device – Product Description 21

BariaTek Medical SAS – Ongoing Clinical Trials Overview 22

Bariatric Minimally Invasive Device – First-in-human Clinical Trial of BariTon in Subjects with Type 2 Diabetes 23

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24

Endo-Luminal Surgery Tool – Product Status 24

Endo-Luminal Surgery Tool – Product Description 24

Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 25

Fiber-Top Controlled Adaptable Stiffness Needle – Product Status 25

Fiber-Top Controlled Adaptable Stiffness Needle – Product Description 25

Low-friction Surgical Grasper – Product Status 26

Low-friction Surgical Grasper – Product Description 26

Distalmotion SA Pipeline Products & Ongoing Clinical Trials Overview 27

Disposable Surgical Device – Product Status 27

Disposable Surgical Device – Product Description 27

Reusable Surgical Device – Product Status 28

Reusable Surgical Device – Product Description 28

Eindhoven University of Technology Pipeline Products & Ongoing Clinical Trials Overview 29

PITON Teleoperated Steerable Needle System – Product Status 29

PITON Teleoperated Steerable Needle System – Product Description 29

ES Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30

CLI Endostapler – Product Status 30

CLI Endostapler – Product Description 30

Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Magnetic Anchoring And Guidance System – Product Status 31

Magnetic Anchoring And Guidance System – Product Description 31

Ezisurg Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

Cavity Mirror System – Product Status 32

Cavity Mirror System – Product Description 32

GT Metabolic Solutions Pipeline Products & Ongoing Clinical Trials Overview 33

Incisionless Duodenal Ilial Bypass Anastomosis Device – Bariatric Surgery – Product Status 33

Incisionless Duodenal Ilial Bypass Anastomosis Device – Bariatric Surgery – Product Description 33

Incisionless Duodenal Ilial Bypass Anastomosis Device – Metabolic Surgery – Product Status 34

Incisionless Duodenal Ilial Bypass Anastomosis Device – Metabolic Surgery – Product Description 34

GT Metabolic Solutions – Ongoing Clinical Trials Overview 35

Incisionless Duodenal Ilial Bypass Anastomosis Device – Metabolic Surgery – Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions DI Bio-fragmentable Magnetic Anastomosis System to Achieve Duodeno-Ileostomy Diversion in Adults With Obesity and Type 2 Diabetes Mellitus 36

Incisionless Duodenal Ilial Bypass Anastomosis Device – Metabolic Surgery – Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions Magnetic Anastomosis System (MAGNET System) to Achieve Duodeno-Ileostomy Diversion in Adults With Obesity and With or Without Type 2 Diabetes Mellitus 36

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 37

iSnake Surgical System – Product Status 37

iSnake Surgical System – Product Description 37

Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Next-Generation Multiport System – Product Status 38

Next-Generation Multiport System – Product Description 38

Jiangsu Jiyuan Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Disposable Gynecological Minimally Invasive Surgical Instrument – Product Status 39

Disposable Gynecological Minimally Invasive Surgical Instrument – Product Description 39

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 40

Dexterous Tool – Surgical Procedures – Product Status 40

Dexterous Tool – Surgical Procedures – Product Description 40

Lapovations LLC Pipeline Products & Ongoing Clinical Trials Overview 41

Second Generation AbGrab – Product Status 41

Second Generation AbGrab – Product Description 41

LXS Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Novel Catheter Device – Product Status 42

Novel Catheter Device – Product Description 42

Medacta Group SA Pipeline Products & Ongoing Clinical Trials Overview 43

Robotic Leg Positioner – Product Status 43

Robotic Leg Positioner – Product Description 43

NanoLite Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 44

SurgiEye – Product Status 44

SurgiEye – Product Description 44

Osaka University Pipeline Products & Ongoing Clinical Trials Overview 45

Minimal Access Surgical Instrument – Product Status 45

Minimal Access Surgical Instrument – Product Description 45

Prana Thoracic Inc Pipeline Products & Ongoing Clinical Trials Overview 46

ThoraCore System – Product Status 46

ThoraCore System – Product Description 46

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 47

Surgical Master-Slave Manipulator – Product Status 47

Surgical Master-Slave Manipulator – Product Description 47

Qingdao Jianxin Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Inteliigent Twin-Engine Dynamic Hybrid Energy Surgery System – Product Status 48

Inteliigent Twin-Engine Dynamic Hybrid Energy Surgery System – Product Description 48

Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 49

Surgical Device – Minimally Invasive Surgery – Product Status 49

Surgical Device – Minimally Invasive Surgery – Product Description 49

Ronovo Surgical (Shanghai) Medical Science and Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

MIS System – Product Status 50

MIS System – Product Description 50

Signum Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

BioHealx Device – Product Status 51

BioHealx Device – Product Description 51

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 52

Minimally Invasive Device – Gastrointestinal Bleeding – Product Status 52

Minimally Invasive Device – Gastrointestinal Bleeding – Product Description 52

UltraSurge Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53

UltraSurge’s Device – Product Status 53

UltraSurge’s Device – Product Description 53

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 54

Transcolonic Overtube For NOTES – Product Status 54

Transcolonic Overtube For NOTES – Product Description 54

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 55

Interleaved Continuum-rigid Manipulator – Product Status 55

Interleaved Continuum-rigid Manipulator – Product Description 55

Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

ArthroTense – Product Status 56

ArthroTense – Product Description 56

VenX Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57

VenX Reach – Product Status 57

VenX Reach – Product Description 57

Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 58

Magnetoelectric Device – Product Status 58

Magnetoelectric Device – Product Description 58

West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 59

Steerable Drill-Driver – Product Status 59

Steerable Drill-Driver – Product Description 59

Steerable Plate Positioner-Stabilizer – Product Status 60

Steerable Plate Positioner-Stabilizer – Product Description 60

Glossary 107

Figures

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 10

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Territory 11

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Regulatory Path 12

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Estimated Approval Date 13

Minimally Invasive Surgical (MIS) devices – Ongoing Clinical Trials 14

Frequently asked questions

Minimally Invasive Surgical (MIS) Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Minimally Invasive Surgical (MIS) Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Minimally Invasive Surgical (MIS) Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Minimally Invasive Surgical (MIS) Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.